An exploratory study the Food and Drug Administration is funding about what US consumers kratom users know about the botanical appears to some as an attempt to gather information to support a conclusion the agency’s already reached.
Latest Kratom Study Unlikely To Change FDA Stance
Critics expect FDA already has reached conclusion about compelling making kratom a controlled substance. “Their conclusion seems to be pretty well preordained,” says NPA CEO Daniel Fabricant.
